Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
17
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Government on J&J's economic contribution to Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Taoiseach Micheál Martin (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meetings with Government Ministers, parliamentarians, and officials with the US Chamber of Commerce delegation in February 2026 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Trade | Engagement with officials in Department of the Taoiseach (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Courtesy call with an Taoiseach (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | EU Affairs | Engagement with the Taoiseach on the review of the EU general pharmaceutical legislation. (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with the Taoiseach on medicines access for patients in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Welcome letters to new Taoiseach and Minister for Enterprise, Trade & Employment (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government Ministers about Budget 2024 (Matters involving public funds) | 9 | On lobbying.ie |
| May–Aug 2022 | Janssen Sciences Ireland UC | Health | J&J hosted an exhibit at the ALDE Congress in Dublin, which showcased health and life sciences innovation from across Europe, including cutting edge treatments for cancer, robotic surgery and 3D printing,… (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Event at the DePuy Synthes site in Co. Cork to mark the formal launch of Johnson & Johnson entering into an eight-year corporate power purchase agreement in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) | 10 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | European Innovation Scorecard 2021 with a focus on Ireland’s performance and areas for improvement (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on the importance of strong communication between Government and industry, especially in the handling issues such as Brexit and the COVID19 crisis (including the vaccine); importance of new policy… (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | Janssen Sciences Ireland UC | Health | Invite to visit Janssen garden ‘Grounded’ at Bloom in the Park festival (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Impact of Brexit on the Life Sciences Sector (Public policy or programme) | 4 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 7 | 41.2% | |
| Health | 7 | 41.2% | |
| Budgetary matters | 1 | 5.9% | |
| EU Affairs | 1 | 5.9% | |
| Trade | 1 | 5.9% |